Cargando…

Effects of sulfonylurea as initial treatment on testosterone of middle-aged men with type 2 diabetes: A 16-week, pilot study

AIMS/INTRODUCTION: To evaluate the effect of sulfonylurea (glimepiride)-based oral antidiabetic agents on testosterone levels in middle-aged men with type 2 diabetes. MATERIALS AND METHODS: As a substudy, 15 participants from the phase IV clinical trial of glimepiride (GREAT study) of middle-aged me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Long, Chen, Hong-Mei, Lai, Shui-Qing, Yang, Hua-Zhang, Kuang, Jian, Pei, Jian-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511305/ https://www.ncbi.nlm.nih.gov/pubmed/26221524 http://dx.doi.org/10.1111/jdi.12324

Ejemplares similares

Sugar-sweetened beverage intake and serum testosterone levels in adult males 20–39 years old in the United States
por: Chen, Liang, et al.
Publicado: (2018)

OR16-5 Feedback on LH in Testosterone-Clamped Men Depends on the Mode of Testosterone Administration and Body Composition
por: Roelfsema, Ferdinand, et al.
Publicado: (2019)

Individual and joint association of bioavailable testosterone and aging with neutrophil-to-lymphocyte ratio in Chinese middle-aged and elderly men
por: Zhou, Jian, et al.
Publicado: (2019)

Testosterone and gonadotropins but not SHBG vary with CKD stages in young and middle aged men
por: Hylander, Britta, et al.
Publicado: (2015)

Reduction of Sulfonylurea with the Initiation of Basal Insulin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Undergoing Long-Term Sulfonylurea-Based Treatment
por: Yang, Yeoree, et al.
Publicado: (2016)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Nordio, Maurizio, et al.
Publicado: (2021)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Changes of Serum Adiponectin and Testosterone Concentrations Following Twelve Weeks Resistance Training in Obese Young Men
por: Moradi, Fatah
Publicado: (2015)

The Effect of Testosterone on Men With Andropause
por: Sofimajidpour, Heshmatollah, et al.
Publicado: (2015)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

Association between serum total testosterone and Body Mass Index in middle aged healthy men
por: Shamim, Muhammad Omar, et al.
Publicado: (2015)

Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer
por: Llukani, Elton, et al.
Publicado: (2017)

Inverse association between serum bilirubin level and testosterone deficiency in middle-aged and older men
por: Park, Hye-Min, et al.
Publicado: (2021)

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
por: Apostolov, Ross, et al.
Publicado: (2022)

Sulfonylurea action re‐revisited
por: Seino, Susumu, et al.
Publicado: (2010)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2016)

Effect of 16 Weeks of Resistance Training on Fatigue Resistance in Men and Women
por: Ribeiro, Alex S., et al.
Publicado: (2014)

Testosterone replacement therapy for older men
por: Borst, Stephen E, et al.
Publicado: (2007)

Testosterone: Bad for Men, Good for Women?
por: van der Wall, E. E.
Publicado: (2010)

Testosterone Administration Reduces Lying in Men
por: Wibral, Matthias, et al.
Publicado: (2012)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

Risks of testosterone therapy in elderly men
por: Ramasamy, Ranjith, et al.
Publicado: (2014)

Transdermal testosterone replacement therapy in men
por: Ullah, M Iftekhar, et al.
Publicado: (2014)

Testosterone Deficiency, Weakness, and Multimorbidity in Men
por: Peterson, Mark D., et al.
Publicado: (2018)

Testosterone levels in men with chronic migraine
por: Shields, Lisa B.E., et al.
Publicado: (2019)

The Effects of Testosterone on the Brain of Transgender Men
por: Zubiaurre-Elorza, Leire, et al.
Publicado: (2021)

Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
por: Walsh, Thomas J., et al.
Publicado: (2018)

Testosterone Therapy for Men With Age-Related Low Testosterone: Tempest in a Teacup
por: Basaria, Shehzad
Publicado: (2021)

A LuALS Mutation with High Sulfonylurea Herbicide Resistance in Linum usitatissimum L.
por: Liu, Caiyue, et al.
Publicado: (2023)

Sulfonylureas: Assets in the past, present and future
por: Kalra, Sanjay, et al.
Publicado: (2015)

Sulfonylureas: Scoring beyond START STUDY
por: Shaikh, Altamash
Publicado: (2017)

Sulfonylurea and neuroprotection: The bright side of the moon
por: Hussien, Nawar R., et al.
Publicado: (2018)

The Place of Sulfonylureas in Guidelines: Why Are There Differences?
por: Amod, Aslam
Publicado: (2020)

Latest Evidence on Sulfonylureas: What’s New?
por: Leiter, Lawrence A.
Publicado: (2020)

Role of Octreotide in Sulfonylurea-Induced Hypoglycemia
por: Zafar, Sheema, et al.
Publicado: (2021)

Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects with Type 2 Diabetes Mellitus
por: Fu, Alex Z., et al.
Publicado: (2012)

Commentary on “Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force”
por: Singh, S. K.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6nchmutenii9uashe94b4odm1m